Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income

Group 1 - Pfizer Inc. is recognized as one of the 10 highest dividend-paying stocks in the S&P 500 [1] - The company has made significant acquisitions to enhance its drug pipeline, including a $43 billion acquisition of Seagen and a $4.9 billion purchase of Metsera [2] - Pfizer has a strong track record of dividend payments, having raised its payouts for 15 consecutive years, with a current quarterly dividend of $0.43 per share and a dividend yield of 7.24% as of September 27 [3] Group 2 - The products from Metsera are aimed at the growing GLP-1 market, although it is too early to determine their success in clinical trials [3] - Pfizer's core business fundamentals suggest that the stock may be attractive for long-term investment [3]